Sign in to view content

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

Raj K. Maturi, MD

Video
Published 2021

Related

Endophthalmitis After Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Inhibitors: Management and Visual Outcomes
Kunyong Xu, MD, MHSc
Annual Meeting Talks
2018
Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Updates from the Field
2022
Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibiz
Susan B. Bressler, MD, FASRS
Updates from the Field
2017

Category: Diabetic Retinopathy

See more